✦ LIBER ✦

Adrenal transplant, dopaminergic neurons, and Parkinson' disease

✍ Scribed by PhD P. Anglade; PhD E. C. Hirsch; MD J. P. Brandel; PhD F. Javoy-Agid; MD; PhD C. Duyckaerts; MD J. J. Hauw; MD; PhD Y. Agid

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 432 KB
Volume: 33
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410330623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopaminergic neurons degenerate by apopt

Dopaminergic neurons degenerate by apoptosis in Parkinson's disease

✍ Etienne C. Hirsch; Stéphane Hunot; Baptiste Faucheux; Yves Agid; Yoshikuni Mizun 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Preservation of hypothalamic dopaminergi

Preservation of hypothalamic dopaminergic neurons in Parkinson's disease

✍ Martin M. Matzuk; Dr. Clifford B. Saper 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 2 views

Striatal dopaminergic neurons are lost w

Striatal dopaminergic neurons are lost with Parkinson's disease progression

✍ Michelle J. Porritt; Ann E. Kingsbury; Andrew J. Hughes; David W. Howells 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract Increased numbers of dopaminergic neurons are described in the striatum of patients with Parkinson's disease. In postmortem striatal tissue from Parkinson's disease patients with short disease duration (≤8 years), the number of dopaminergic neurons is approximately four times that in pa

Dopaminergic transplantation for parkins

Dopaminergic transplantation for parkinson's disease: Current status and future prospects

✍ C. Warren Olanow; Jeffrey H. Kordower; Anthony E. Lang; Jose A. Obeso 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

## Abstract Cell‐based therapies that involve transplantation into the striatum of dopaminergic cells have attracted considerable interest as possible treatments for Parkinson's disease (PD). However, all double‐blind, sham‐controlled, studies have failed to meet their primary endpoints, and transp

Adrenal medulla and Parkinson's disease

✍ Susan L. Stoddard; Glenn J. Merkel; Jennifer A. Cook; Alan R. Zinsmeister; Steph 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

## Abstract Parkinson's disease has been described as a multisystem disorder that includes alterations in the function of the autonomic nervous system. The activity of the adrenal medulla in this disease has not been thoroughly investigated. Previous reports are reviewed that demonstrate that the a

Therapies for dopaminergic-induced dyski

Therapies for dopaminergic-induced dyskinesias in parkinson disease

✍ Mildred D. Gottwald; Michael J. Aminoff 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 2 views

## Abstract Existing and emerging strategies for managing L‐dopa–induced dyskinesias (LIDs) in patients with Parkinson disease have involved either delaying the introduction of L‐dopa therapy, treatment with an antidyskinetic agent, using a therapy or delivery system that can provide continuous dop